Brazil Unveils National Strategy to Propel Science and Technology Innovation Through 2034

Brazil has officially approved its National Strategy for Science, Technology, and Innovation, aiming to modernize its technology sector and boost global competitiveness by 2034. Announced on August 2, 2026, the strategy focuses on reinforcing public policies to stimulate innovation, particularly in generative artificial intelligence and digital regulatory frameworks.

Vice President Geraldo Alckmin emphasized the critical importance of developing a high-tech industry to enhance national income and competitiveness globally. Key to this plan is fostering an innovation-friendly environment, encouraging startups growth, notably in fintech and healthtech industries, and advancing Brazil's digital infrastructure, including expanding 5G coverage and preparing for future 6G networks.

The strategy also seeks to place Brazil prominently in international dialogues concerning the regulation of emerging technologies. This international integration is vital to align Brazil’s innovation efforts with global standards and trends.

Experts at the 78th Annual Meeting of the Brazilian Society for the Progress of Science underscored infrastructure as a linchpin for Brazil’s scientific leadership. Despite a current investment of 1.2% of GDP in research and development, specialists such as Francilene Garcia, SBPC president, advocate increasing this to 2% to adequately meet national challenges. Celina Pereira from the Ministry of Management and Innovation highlighted the importance of institutional governance and coordination, citing successful applications in health and environmental data sectors.

Osvaldo Moraes from the Ministry of Science, Technology and Innovation cited achievements like the National Synchrotron Light Laboratory (Sirius) while pointing out slower advancements in nuclear research. On the health front, Fernanda De Negri of the Ministry of Health stressed the pressing need for innovation to tackle issues like an aging population and the lack of infrastructure that translates scientific research into healthcare solutions. Initiatives like Genomas Brasil aim to support precision medicine by building a comprehensive genomic database tailored to Brazil's population.

Together, these efforts underscore Brazil’s capacity to lead in global science and technology, contingent on strengthening infrastructure, governance, and investment to transform innovations into impactful, high-tech advancements.